Sam Klempner
@KlempnerSam
GI medical oncologist focusing on stomach and esophageal cancer research at Massachusetts General Hospital, Harvard Medical School
ID:1086165456757477377
18-01-2019 07:36:39
1,1K تغريدات
3,4K متابعون
651 التالية
Follow People
Out online in parallel with Scott Kopetz #AACR24 presentation. Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12C-Mutated Metastatic Colorectal Cancer. Nataliya Uboha Rona Yaeger Tanios Bekaii-Saab, MD Cancer Discovery Marcia Cruz-Correa, MD, PhD aacrjournals.org/cancerdiscover…
Was a pleasure to work on the #HPB #OG Scientific Committee for #ASCO24 Thanks to Sam Klempner for your leadership and to all for lively discussions and to ASCO for co-ordinating. Great to see Patrick Forde also.
#ICYMI : Sequential #chemoimmunotherapy in #gastriccancer , by minae an, Arnav Mehta, Byung Hoon Min, You Jeong Heo, Seung Tae Kim, Sam Klempner, Jeeyun Lee MD et al.
bit.ly/48oMuMz
Mass General Cancer Center @Broadinstitute #SamsungMedicalCenter SU2Cscience
Now online in Cancer Discovery: Early Immune Remodeling Steers Clinical Response to Frontline Chemoimmunotherapy in Advanced Gastric Cancer - by minae an, Arnav Mehta, Byung Hoon Min, You Jeong Heo, Seung Tae Kim, Sam Klempner, Jeeyun Lee MD et al. doi.org/10.1158/2159-8…
Happy to share latest international collaboration led by awesome Arnav Mehta minae an and others. Jeeyun Lee MD Cancer Discovery SU2Cscience
Early immune remodeling steers clinical response to frontline chemoimmunotherapy in advanced gastric. aacrjournals.org/cancerdiscover…
MassGeneral Medicine Mass General Cancer Center with lots of representation at Stand Up To Cancer
Erica Warner, ScD David A. Drew Justin Gainor Sam Klempner and missing a few here like Adjoa Anyane-Yeboa, MD MPH Andy Chan and few others non on “x”
What a great start of 2024! Excited, happy and proud to share our latest work published today #openaccess Nature Medicine on the PANDA trial: neoadjuvant atezo+chemo in pts with gastric/GEJ cancers followed by surgery. Some of the key findings below. 1/10 nature.com/articles/s4159…
KEYNOTE-585 is published The Lancet Oncology as presented at #ESMO24 . Pembro+chemo improved pathCR of #gastriccancer but EFS was not statistically significant. MSI-H is distinguished population. Full results of Matterhorn awaited. OncoAlert ESMO - Eur. Oncology ASCO
thelancet.com/journals/lanon…
Thankful for friends/colleagues/mentors like Jeeyun Lee MD. Leveraging ex-vivo system to interrogate exosomes in gastric cancer. #StomachCancerAwareness month.
Patient-derived exosomes facilitate therapeutic targeting of oncogenic MET in advanced GC
science.org/doi/10.1126/sc…
Two fantastic #ASCOplenary sessions around #upperGI cancers tomorrow. Not to miss!
Yelena Y. Janjigian MD Sam Klempner Lizzy Smyth ASCO OncoAlert Tanios Bekaii-Saab, MD
🪚CLAUDIN 18.2 has been a topic of discussion, & there’s fresh & emerging treatments for #GastricCancer
🇮🇪Join Sam Klempner Darren Cowzer on #TumorBoardTuesday Sept 26 to explore further
🌍Dive into this global discussion at 8pm EDT / 1am IST
FREE #CME 👉🏽integrityce.com/TBT2023
🚨 Hey junior faculty and early career GI oncology docs:
There’s room at the NRG Oncology GI Onc table if you want to get more involved with National Cancer Institute NCI CTEP Clinical Research clinical trials.
Gotta’ apply though …. 👇🏻
Ted Hong
ILSON David
Scott Kopetz
Heloisa Soares MD
Annual Symposium on Upper Gastro-Intestinal Cancers- McGill University. Oct 28 in Montreal. Multidisciplinary and Multinational varied perspectives on esophageal and gastric cancer. Sam Klempner MarkvanBergeHenegouwen Suzanne Gisbertz and more X-less speakers. mcgill.ca/thoracic/event…
New research - Reynolds et al - Trimodality therapy vs perioperative chemotherapy for locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction: the Neo-AEGIS phase 3 trial
thelancet.com/journals/langa…
#OncTwitter #GITwitter #EsoCSM